CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The NanoSil4Cancer project aims to develop smart nanoparticles for targeted cancer therapy, enhancing drug delivery while minimizing side effects. This technology focuses on creating pH-sensitive pro-drugs that release medication specifically in cancer cells.
NanoSil4Cancer project will be able to accelerate the uptake of nanotechnologies, by developing, mesoporous silica-based prototypes of nano-vehicles, according to an innovative and proprietary approach (EP06745236), active in smart chemotherapy.
This is aimed to minimize toxicity and the side effects of the traditional antitumor agents and to increase their therapeutic potential.
This technology platform enables customers’ molecules to be formulated as pH–sensitive pro-drugs and introduced in sm…
NANOSILICAL DEVICES SRL
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
